225 related articles for article (PubMed ID: 15765147)
1. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.
Curreli F; Friedman-Kien AE; Flore O
J Clin Invest; 2005 Mar; 115(3):642-52. PubMed ID: 15765147
[TBL] [Abstract][Full Text] [Related]
2. Licking latency with licorice.
Cohen JI
J Clin Invest; 2005 Mar; 115(3):591-3. PubMed ID: 15765143
[TBL] [Abstract][Full Text] [Related]
3. Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection.
Burrer CM; Foight GW; Keating AE; Chan GC
Virus Res; 2016 Jan; 211():86-8. PubMed ID: 26456186
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.
Jeong J; Papin J; Dittmer D
J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678
[TBL] [Abstract][Full Text] [Related]
7. Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells.
Gonnella R; Yadav S; Gilardini Montani MS; Granato M; Santarelli R; Garufi A; D'Orazi G; Faggioni A; Cirone M
Free Radic Biol Med; 2017 Nov; 112():327-335. PubMed ID: 28801242
[TBL] [Abstract][Full Text] [Related]
8. p53 inhibition by the LANA protein of KSHV protects against cell death.
Friborg J; Kong W; Hottiger MO; Nabel GJ
Nature; 1999 Dec 23-30; 402(6764):889-94. PubMed ID: 10622254
[TBL] [Abstract][Full Text] [Related]
9. Nutlin-3 induces apoptosis, disrupts viral latency and inhibits expression of angiopoietin-2 in Kaposi sarcoma tumor cells.
Ye F; Lattif AA; Xie J; Weinberg A; Gao S
Cell Cycle; 2012 Apr; 11(7):1393-9. PubMed ID: 22421142
[TBL] [Abstract][Full Text] [Related]
10. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
[TBL] [Abstract][Full Text] [Related]
11. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
[TBL] [Abstract][Full Text] [Related]
12. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
14. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha.
Wu FY; Tang QQ; Chen H; ApRhys C; Farrell C; Chen J; Fujimuro M; Lane MD; Hayward GS
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10683-8. PubMed ID: 12145325
[TBL] [Abstract][Full Text] [Related]
15. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation.
Yang M; Huang L; Li X; Kuang E
Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848
[TBL] [Abstract][Full Text] [Related]
16. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation.
Angius F; Piras E; Uda S; Madeddu C; Serpe R; Bigi R; Chen W; Dittmer DP; Pompei R; Ingianni A
J Antibiot (Tokyo); 2017 Aug; 70(9):962-966. PubMed ID: 28611469
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
Si H; Robertson ES
J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency.
Cai Q; Verma SC; Choi JY; Ma M; Robertson ES
J Virol; 2010 Nov; 84(21):11134-44. PubMed ID: 20719954
[TBL] [Abstract][Full Text] [Related]
20. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
Rajćáni J; Kúdelová M
Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]